Cognex (CGNX) Cash & Equivalents (2009 - 2026)

Cognex has reported Cash & Equivalents for 18 years, with the latest figure at $237.3 million in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 65.12% year-over-year to $237.3 million; the trailing twelve-month figure through Apr 2026 stood at $237.3 million (up 65.12% YoY), and the FY2025 full-year result was $262.9 million, up 41.29% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $237.3 million, down from $262.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $395.5 million in Q4 2023, with the low at $7.0 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $196.4 million across 5 years, with a median of $181.4 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 97.12% — and 2023, when it jumped 2244.97%.
• Cognex's Cash & Equivalents stood at $181.4 million in 2022, then increased by 11.73% to $202.7 million in 2023, then decreased by 8.17% to $186.1 million in 2024, then surged by 41.29% to $262.9 million in 2025, then declined by 9.73% to $237.3 million in 2026.
• The last three Cash & Equivalents figures came in at $237.3 million (Q2 2026), $262.9 million (Q4 2025), and $245.9 million (Q3 2025), per Business Quant data.